img

Global Radiopharmaceutical Therapy Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiopharmaceutical Therapy Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Radiopharmaceutical Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Radiopharmaceutical Therapy market is projected to reach US$ 8804.1 million in 2034, increasing from US$ 6761 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Radiopharmaceutical Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Radiopharmaceutical Therapy key companies include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. Bracco Imaging, Bayer, Mallinckrodt are top 3 players and held % share in total in 2022.
Radiopharmaceutical Therapy can be divided into Actinium-225, Lutetium-177, Radium-223 and Holmium-166, etc. Actinium-225 is the mainstream product in the market, accounting for % share globally in 2022.
Radiopharmaceutical Therapy is widely used in various fields, such as Oncology, Cardiology and Other,, etc. Oncology provides greatest supports to the Radiopharmaceutical Therapy industry development. In 2022, global % share of Radiopharmaceutical Therapy went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Radiopharmaceutical Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Segment by Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other

Segment by Application


Oncology
Cardiology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Radiopharmaceutical Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Radiopharmaceutical Therapy introduction, etc. Radiopharmaceutical Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Radiopharmaceutical Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Radiopharmaceutical Therapy
1.1 Radiopharmaceutical Therapy Market Overview
1.1.1 Radiopharmaceutical Therapy Product Scope
1.1.2 Radiopharmaceutical Therapy Market Status and Outlook
1.2 Global Radiopharmaceutical Therapy Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Radiopharmaceutical Therapy Market Size by Region (2024-2034)
1.4 Global Radiopharmaceutical Therapy Historic Market Size by Region (2024-2024)
1.5 Global Radiopharmaceutical Therapy Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Radiopharmaceutical Therapy Market Size (2024-2034)
1.6.1 North America Radiopharmaceutical Therapy Market Size (2024-2034)
1.6.2 Europe Radiopharmaceutical Therapy Market Size (2024-2034)
1.6.3 Asia-Pacific Radiopharmaceutical Therapy Market Size (2024-2034)
1.6.4 Latin America Radiopharmaceutical Therapy Market Size (2024-2034)
1.6.5 Middle East & Africa Radiopharmaceutical Therapy Market Size (2024-2034)
2 Radiopharmaceutical Therapy Market by Type
2.1 Introduction
2.1.1 Actinium-225
2.1.2 Lutetium-177
2.1.3 Radium-223
2.1.4 Holmium-166
2.1.5 Other
2.2 Global Radiopharmaceutical Therapy Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Radiopharmaceutical Therapy Historic Market Size by Type (2024-2024)
2.2.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Radiopharmaceutical Therapy Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Radiopharmaceutical Therapy Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Radiopharmaceutical Therapy Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Radiopharmaceutical Therapy Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Radiopharmaceutical Therapy Revenue Breakdown by Type (2024-2034)
3 Radiopharmaceutical Therapy Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Other
3.2 Global Radiopharmaceutical Therapy Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Radiopharmaceutical Therapy Historic Market Size by Application (2024-2024)
3.2.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Radiopharmaceutical Therapy Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Radiopharmaceutical Therapy Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Radiopharmaceutical Therapy Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Radiopharmaceutical Therapy Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Radiopharmaceutical Therapy Revenue Breakdown by Application (2024-2034)
4 Radiopharmaceutical Therapy Competition Analysis by Players
4.1 Global Radiopharmaceutical Therapy Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
4.3 Date of Key Players Enter into Radiopharmaceutical Therapy Market
4.4 Global Top Players Radiopharmaceutical Therapy Headquarters and Area Served
4.5 Key Players Radiopharmaceutical Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Radiopharmaceutical Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bracco Imaging
5.1.1 Bracco Imaging Profile
5.1.2 Bracco Imaging Main Business
5.1.3 Bracco Imaging Radiopharmaceutical Therapy Products, Services and Solutions
5.1.4 Bracco Imaging Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.1.5 Bracco Imaging Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Radiopharmaceutical Therapy Products, Services and Solutions
5.2.4 Bayer Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.2.5 Bayer Recent Developments
5.3 Mallinckrodt
5.3.1 Mallinckrodt Profile
5.3.2 Mallinckrodt Main Business
5.3.3 Mallinckrodt Radiopharmaceutical Therapy Products, Services and Solutions
5.3.4 Mallinckrodt Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.3.5 Nordion Recent Developments
5.4 Nordion
5.4.1 Nordion Profile
5.4.2 Nordion Main Business
5.4.3 Nordion Radiopharmaceutical Therapy Products, Services and Solutions
5.4.4 Nordion Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.4.5 Nordion Recent Developments
5.5 Triad Isotopes
5.5.1 Triad Isotopes Profile
5.5.2 Triad Isotopes Main Business
5.5.3 Triad Isotopes Radiopharmaceutical Therapy Products, Services and Solutions
5.5.4 Triad Isotopes Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.5.5 Triad Isotopes Recent Developments
5.6 Lantheus
5.6.1 Lantheus Profile
5.6.2 Lantheus Main Business
5.6.3 Lantheus Radiopharmaceutical Therapy Products, Services and Solutions
5.6.4 Lantheus Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.6.5 Lantheus Recent Developments
5.7 IBA Group
5.7.1 IBA Group Profile
5.7.2 IBA Group Main Business
5.7.3 IBA Group Radiopharmaceutical Therapy Products, Services and Solutions
5.7.4 IBA Group Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.7.5 IBA Group Recent Developments
5.8 GE Healthcare
5.8.1 GE Healthcare Profile
5.8.2 GE Healthcare Main Business
5.8.3 GE Healthcare Radiopharmaceutical Therapy Products, Services and Solutions
5.8.4 GE Healthcare Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.8.5 GE Healthcare Recent Developments
5.9 China Isotope & Radiation
5.9.1 China Isotope & Radiation Profile
5.9.2 China Isotope & Radiation Main Business
5.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Products, Services and Solutions
5.9.4 China Isotope & Radiation Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.9.5 China Isotope & Radiation Recent Developments
5.10 Jubilant Pharma
5.10.1 Jubilant Pharma Profile
5.10.2 Jubilant Pharma Main Business
5.10.3 Jubilant Pharma Radiopharmaceutical Therapy Products, Services and Solutions
5.10.4 Jubilant Pharma Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.10.5 Jubilant Pharma Recent Developments
5.11 Eli Lilly
5.11.1 Eli Lilly Profile
5.11.2 Eli Lilly Main Business
5.11.3 Eli Lilly Radiopharmaceutical Therapy Products, Services and Solutions
5.11.4 Eli Lilly Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.11.5 Eli Lilly Recent Developments
5.12 Advanced Accelerator Applications
5.12.1 Advanced Accelerator Applications Profile
5.12.2 Advanced Accelerator Applications Main Business
5.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Products, Services and Solutions
5.12.4 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.12.5 Advanced Accelerator Applications Recent Developments
5.13 SIEMENS
5.13.1 SIEMENS Profile
5.13.2 SIEMENS Main Business
5.13.3 SIEMENS Radiopharmaceutical Therapy Products, Services and Solutions
5.13.4 SIEMENS Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.13.5 SIEMENS Recent Developments
5.14 Dongcheng
5.14.1 Dongcheng Profile
5.14.2 Dongcheng Main Business
5.14.3 Dongcheng Radiopharmaceutical Therapy Products, Services and Solutions
5.14.4 Dongcheng Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.14.5 Dongcheng Recent Developments
5.15 Navidea
5.15.1 Navidea Profile
5.15.2 Navidea Main Business
5.15.3 Navidea Radiopharmaceutical Therapy Products, Services and Solutions
5.15.4 Navidea Radiopharmaceutical Therapy Revenue (US$ Million) & (2024-2024)
5.15.5 Navidea Recent Developments
6 North America
6.1 North America Radiopharmaceutical Therapy Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Radiopharmaceutical Therapy Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Radiopharmaceutical Therapy Market Dynamics
11.1 Radiopharmaceutical Therapy Industry Trends
11.2 Radiopharmaceutical Therapy Market Drivers
11.3 Radiopharmaceutical Therapy Market Challenges
11.4 Radiopharmaceutical Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Radiopharmaceutical Therapy Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Radiopharmaceutical Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Radiopharmaceutical Therapy Market Size Share by Region (2024-2024)
Table 4. Global Radiopharmaceutical Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Radiopharmaceutical Therapy Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Radiopharmaceutical Therapy Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Radiopharmaceutical Therapy Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2024)
Table 9. Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Table 11. North America Radiopharmaceutical Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Radiopharmaceutical Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Radiopharmaceutical Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Radiopharmaceutical Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Radiopharmaceutical Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Radiopharmaceutical Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Radiopharmaceutical Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Radiopharmaceutical Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Radiopharmaceutical Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Radiopharmaceutical Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Radiopharmaceutical Therapy Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Radiopharmaceutical Therapy Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2024)
Table 24. Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Table 26. North America Radiopharmaceutical Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Radiopharmaceutical Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Radiopharmaceutical Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Radiopharmaceutical Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Radiopharmaceutical Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Radiopharmaceutical Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Radiopharmaceutical Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Radiopharmaceutical Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Radiopharmaceutical Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Radiopharmaceutical Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Radiopharmaceutical Therapy Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
Table 39. Date of Key Players Enter into Radiopharmaceutical Therapy Market
Table 40. Global Radiopharmaceutical Therapy Key Players Headquarters and Area Served
Table 41. Radiopharmaceutical Therapy Product Solution and Service
Table 42. Global Radiopharmaceutical Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bracco Imaging Basic Information List
Table 45. Bracco Imaging Description and Business Overview
Table 46. Bracco Imaging Radiopharmaceutical Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Bracco Imaging (2024-2024)
Table 48. Bracco Imaging Recent Developments
Table 49. Bayer Basic Information List
Table 50. Bayer Description and Business Overview
Table 51. Bayer Radiopharmaceutical Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Bayer (2024-2024)
Table 53. Bayer Recent Developments
Table 54. Mallinckrodt Basic Information List
Table 55. Mallinckrodt Description and Business Overview
Table 56. Mallinckrodt Radiopharmaceutical Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Mallinckrodt (2024-2024)
Table 58. Mallinckrodt Recent Developments
Table 59. Nordion Basic Information List
Table 60. Nordion Description and Business Overview
Table 61. Nordion Radiopharmaceutical Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Nordion (2024-2024)
Table 63. Nordion Recent Developments
Table 64. Triad Isotopes Basic Information List
Table 65. Triad Isotopes Description and Business Overview
Table 66. Triad Isotopes Radiopharmaceutical Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Triad Isotopes (2024-2024)
Table 68. Triad Isotopes Recent Developments
Table 69. Lantheus Basic Information List
Table 70. Lantheus Description and Business Overview
Table 71. Lantheus Radiopharmaceutical Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Lantheus (2024-2024)
Table 73. Lantheus Recent Developments
Table 74. IBA Group Basic Information List
Table 75. IBA Group Description and Business Overview
Table 76. IBA Group Radiopharmaceutical Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of IBA Group (2024-2024)
Table 78. IBA Group Recent Developments
Table 79. GE Healthcare Basic Information List
Table 80. GE Healthcare Description and Business Overview
Table 81. GE Healthcare Radiopharmaceutical Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of GE Healthcare (2024-2024)
Table 83. GE Healthcare Recent Developments
Table 84. China Isotope & Radiation Basic Information List
Table 85. China Isotope & Radiation Description and Business Overview
Table 86. China Isotope & Radiation Radiopharmaceutical Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of China Isotope & Radiation (2024-2024)
Table 88. China Isotope & Radiation Recent Developments
Table 89. Jubilant Pharma Basic Information List
Table 90. Jubilant Pharma Description and Business Overview
Table 91. Jubilant Pharma Radiopharmaceutical Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Jubilant Pharma (2024-2024)
Table 93. Jubilant Pharma Recent Developments
Table 94. Eli Lilly Basic Information List
Table 95. Eli Lilly Description and Business Overview
Table 96. Eli Lilly Radiopharmaceutical Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Eli Lilly (2024-2024)
Table 98. Eli Lilly Recent Developments
Table 99. Advanced Accelerator Applications Basic Information List
Table 100. Advanced Accelerator Applications Description and Business Overview
Table 101. Advanced Accelerator Applications Radiopharmaceutical Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Advanced Accelerator Applications (2024-2024)
Table 103. Advanced Accelerator Applications Recent Developments
Table 104. SIEMENS Basic Information List
Table 105. SIEMENS Description and Business Overview
Table 106. SIEMENS Radiopharmaceutical Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of SIEMENS (2024-2024)
Table 108. SIEMENS Recent Developments
Table 109. Dongcheng Basic Information List
Table 110. Dongcheng Description and Business Overview
Table 111. Dongcheng Radiopharmaceutical Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Dongcheng (2024-2024)
Table 113. Dongcheng Recent Developments
Table 114. Navidea Basic Information List
Table 115. Navidea Description and Business Overview
Table 116. Navidea Radiopharmaceutical Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Radiopharmaceutical Therapy Business of Navidea (2024-2024)
Table 118. Navidea Recent Developments
Table 119. North America Radiopharmaceutical Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 120. North America Radiopharmaceutical Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 121. Europe Radiopharmaceutical Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 122. Europe Radiopharmaceutical Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 123. Asia-Pacific Radiopharmaceutical Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 125. Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 126. Asia-Pacific Radiopharmaceutical Therapy Market Share by Region (2024-2024)
Table 127. Asia-Pacific Radiopharmaceutical Therapy Market Share by Region (2024-2034)
Table 128. Latin America Radiopharmaceutical Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 129. Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 130. Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 131. Middle East & Africa Radiopharmaceutical Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 132. Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 133. Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 134. Radiopharmaceutical Therapy Market Trends
Table 135. Radiopharmaceutical Therapy Market Drivers
Table 136. Radiopharmaceutical Therapy Market Challenges
Table 137. Radiopharmaceutical Therapy Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiopharmaceutical Therapy Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Radiopharmaceutical Therapy Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Radiopharmaceutical Therapy Market Share by Regions: 2022 VS 2034
Figure 4. Global Radiopharmaceutical Therapy Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Radiopharmaceutical Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Radiopharmaceutical Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Radiopharmaceutical Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Radiopharmaceutical Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Radiopharmaceutical Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Actinium-225
Figure 11. Global Actinium-225 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Lutetium-177
Figure 13. Global Lutetium-177 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Radium-223
Figure 15. Global Radium-223 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Holmium-166
Figure 17. Global Holmium-166 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of Other
Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Global Radiopharmaceutical Therapy Market Size Share by Type: 2022 & 2034
Figure 21. North America Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Figure 22. Europe Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Figure 23. Asia-Pacific Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Figure 24. Latin America Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Figure 25. Middle East and Africa Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2034)
Figure 26. Oncology Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Cardiology Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Global Radiopharmaceutical Therapy Market Size Share by Application: 2022 & 2034
Figure 30. North America Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Figure 31. Europe Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Figure 32. Asia-Pacific Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Figure 33. Latin America Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Figure 34. Middle East and Africa Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2034)
Figure 35. Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 36. Global Top 5 and Top 10 Players Radiopharmaceutical Therapy Market Share in 2022
Figure 37. North America Radiopharmaceutical Therapy Market Share by Country (2024-2034)
Figure 38. United States Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 39. Canada Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 40. Germany Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 41. France Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 42. U.K. Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 43. Italy Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 44. Russia Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 45. Nordic Countries Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 46. Asia-Pacific Radiopharmaceutical Therapy Market Share by Region (2024-2034)
Figure 47. China Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 48. Japan Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 49. South Korea Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 50. Southeast Asia Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 51. India Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 52. Australia Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 53. Latin America Radiopharmaceutical Therapy Market Share by Country (2024-2034)
Figure 54. Mexico Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 55. Brazil Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 56. Middle East & Africa Radiopharmaceutical Therapy Market Share by Country (2024-2034)
Figure 57. Turkey Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 58. Saudi Arabia Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 59. UAE Radiopharmaceutical Therapy Market Size (2024-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report